Cyrus Biotechnology
PrivateLast Round
Seed Round
May 8, 2026
Total Funding Raised
$27.15M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Cyrus Biotechnology is a biotechnology company that develops AI-driven protein engineering technologies to create novel protein therapeutics for autoimmune diseases and other challenging drug targets.
Sector
Enterprise Software
Verticals
Biotechnology, Drug Discovery, Vertical SaaS
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cyrus Biotechnology Comparables
Compare Cyrus Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OpenProtein.AI | 82% | |
| ProteinQure | 79% | |
| Cradle | 77% |
Cyrus Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | May 8, 2026 | ||||
| Grant | Sep 15, 2022 | ||||
| Series B | Dec 6, 2021 | ||||
| Series A | Jul 27, 2017 | ||||
| Seed | Jun 2, 2015 |
Key People
Founding team and executive leadership
Cyrus Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agent Capital | Series B |
| iSelect Fund | Series B |
| National Institute of Allergy and Infectious Diseases | Grant |
| The Yard Ventures | Series B |
| OrbiMed | Series A, Series B |
| Washington Research Foundation Capital | Series A, Series B |
| SpringRock Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased from 0 to 7, representing 41% of headcount.
- May 8, 2026
$1.48M raised in Seed Round.
Cyrus Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cyrus Biotechnology's valuation, stock price, and market status.
Is Cyrus Biotechnology a public or private company?
Cyrus Biotechnology is a private company.
What is the current stock price of Cyrus Biotechnology?
Cyrus Biotechnology is a private company with no public stock price. No recent secondary market data is available.
How much is Cyrus Biotechnology worth (valuation)?
Valuation information for Cyrus Biotechnology is not publicly available.
Can I buy Cyrus Biotechnology stock?
Cyrus Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cyrus Biotechnology's last funding round?
Cyrus Biotechnology's most recent funding round was Seed Round on May 8, 2026.
Who are the main investors in Cyrus Biotechnology?
Key investors in Cyrus Biotechnology include OrbiMed, Trinity Ventures.
Will Cyrus Biotechnology IPO soon?
No public IPO plans have been announced for Cyrus Biotechnology.
How can I track Cyrus Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cyrus Biotechnology's secondary market activity and sign up for updates.